IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Stock Profile — Insider Trades & Financials

Revenue$86.8M

Net Income-$71.9M

EPS$-1.09

Market Cap$1.4B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Frederick Vogt

CEO & Executive Director

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.

Founded: 2007
Employees: 319
Headquarters: SAN CARLOS, CA, United States
Website: www.iovance.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-10.29%

ROA?

-7.87%

D/E Ratio?

0.31

Op. Margin?

-84.66%

📊

Profitability Ratios

Net Margin?

-82.87%

Loading company sections...

IOVANCE BIOTHERAPEUTICS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness